{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,3]],"date-time":"2026-10-03T11:48:03Z","timestamp":1791028083170,"version":"4.1.0"},"reference-count":41,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2021,5,1]],"date-time":"2021-05-01T00:00:00Z","timestamp":1619827200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2021,5,1]],"date-time":"2021-05-01T00:00:00Z","timestamp":1619827200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2021,2,4]],"date-time":"2021-02-04T00:00:00Z","timestamp":1612396800000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"funder":[{"DOI":"10.13039\/100000002","name":"NIH","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100000002","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","ijidonline.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["International Journal of Infectious Diseases"],"published-print":{"date-parts":[[2021,5]]},"DOI":"10.1016\/j.ijid.2021.02.016","type":"journal-article","created":{"date-parts":[[2021,2,10]],"date-time":"2021-02-10T01:59:14Z","timestamp":1612922354000},"page":"83-90","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":15,"special_numbering":"C","title":["Anti-Leishmania IgG is a marker of disseminated leishmaniasis caused by Leishmania braziliensis"],"prefix":"10.1016","volume":"106","author":[{"given":"Andr\u00e9a","family":"Magalh\u00e3es","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lucas P.","family":"Carvalho","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"R\u00fabia","family":"Costa","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"M\u00f4nica S.","family":"Pita","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Thiago Marconi","family":"Cardoso","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Paulo R.L.","family":"Machado","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Edgar M.","family":"Carvalho","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"S\u00e9rgio","family":"Arruda","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Augusto M.","family":"Carvalho","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"12","key":"10.1016\/j.ijid.2021.02.016_bib0005","doi-asserted-by":"crossref","first-page":"6734","DOI":"10.1128\/IAI.70.12.6734-6740.2002","article-title":"Up-regulation of Th1-type responses in mucosal leishmaniasis patients","volume":"70","author":"Bacellar","year":"2002","journal-title":"Infect Immun"},{"key":"10.1016\/j.ijid.2021.02.016_bib0010","series-title":"Evaluation of the micro enzyme-linked immunosorbent assay (ELISA) for antibodies in American visceral leishmaniasis: antigen selection for detection of infection-specific responses","author":"Badar\u00f3","year":"1986"},{"issue":"7","key":"10.1016\/j.ijid.2021.02.016_bib0015","doi-asserted-by":"crossref","first-page":"474","DOI":"10.1111\/j.1365-4362.1995.tb00613.x","article-title":"Polar and subpolar diffuse cutaneous leishmaniasis in Brazil: clinical and immunopathologic aspects","volume":"34","author":"Barral","year":"1995","journal-title":"Int J Dermatol"},{"issue":"1","key":"10.1016\/j.ijid.2021.02.016_bib0020","doi-asserted-by":"crossref","first-page":"51","DOI":"10.1590\/S0074-02761991000100009","article-title":"Evaluation of the histopathological classifications of American cutaneous and mucocutaneous leishmaniasis","volume":"86","author":"Bittencourt","year":"1991","journal-title":"Mem Inst Oswaldo Cruz"},{"issue":"4","key":"10.1016\/j.ijid.2021.02.016_bib0025","doi-asserted-by":"crossref","first-page":"344","DOI":"10.4269\/ajtmh.2002.67.344","article-title":"The sensitivity and specificity of Leishmania chagasi recombinant K39 antigen in the diagnosis of American visceral leishmaniasis and in differentiating active from subclinical infection","volume":"67","author":"Braz","year":"2002","journal-title":"Am J Trop Med Hyg"},{"issue":"3","key":"10.1016\/j.ijid.2021.02.016_bib0030","doi-asserted-by":"crossref","first-page":"527","DOI":"10.1093\/infdis\/jiaa374","article-title":"Impaired Th1 response is associated therapeutic failure in patients with cutaneous leishmaniasis caused by Leishmania braziliensis","volume":"223","author":"Carvalho","year":"2020","journal-title":"J Infect Dis"},{"key":"10.1016\/j.ijid.2021.02.016_bib0035","doi-asserted-by":"crossref","first-page":"529","DOI":"10.1186\/1471-2334-13-529","article-title":"Immunologic response and memory T cells in subjects cured of tegumentary leishmaniasis","volume":"13","author":"Carvalho","year":"2013","journal-title":"BMC Infect Dis"},{"issue":"6","key":"10.1016\/j.ijid.2021.02.016_bib0040","doi-asserted-by":"crossref","first-page":"2066","DOI":"10.1172\/JCI112209","article-title":"Absence of gamma interferon and interleukin 2 production during active visceral leishmaniasis","volume":"76","author":"Carvalho","year":"1985","journal-title":"J Clin Invest"},{"issue":"4","key":"10.1016\/j.ijid.2021.02.016_bib0045","doi-asserted-by":"crossref","first-page":"315","DOI":"10.1016\/0001-706X(94)90103-1","article-title":"Clinical and immunopathological aspects of disseminated cutaneous leishmaniasis","volume":"56","author":"Carvalho","year":"1994","journal-title":"Acta Trop"},{"issue":"6","key":"10.1016\/j.ijid.2021.02.016_bib0050","doi-asserted-by":"crossref","first-page":"4144","DOI":"10.4049\/jimmunol.135.6.4144","article-title":"Cell mediated immunity in American cutaneous and mucosal leishmaniasis","volume":"135","author":"Carvalho","year":"1985","journal-title":"J Immunol"},{"issue":"3","key":"10.1016\/j.ijid.2021.02.016_bib0055","doi-asserted-by":"crossref","first-page":"295","DOI":"10.1016\/S0001-706X(99)00005-4","article-title":"Polymerase chain reaction reveals Trypanosoma cruzi infection suspected by serology in cutaneous and mucocutaneous leishmaniasis patients","volume":"72","author":"Chiaramonte","year":"1999","journal-title":"Acta Trop"},{"issue":"3","key":"10.1016\/j.ijid.2021.02.016_bib0060","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pntd.0007152","article-title":"Host and parasite responses in human diffuse cutaneous leishmaniasis caused by L. amazonensi","volume":"13","author":"Christensen","year":"2019","journal-title":"PLoS Negl Trop Dis"},{"issue":"8","key":"10.1016\/j.ijid.2021.02.016_bib0065","doi-asserted-by":"crossref","DOI":"10.1128\/JCM.00762-19","article-title":"Cross-reactivity using chimeric Trypanosoma cruzi antigens: diagnostic performance in settings where chagas disease and American cutaneous or visceral leishmaniasis are coendemic","volume":"57","author":"Daltro","year":"2019","journal-title":"J Clin Microbiol"},{"issue":"10","key":"10.1016\/j.ijid.2021.02.016_bib0070","doi-asserted-by":"crossref","first-page":"486","DOI":"10.1111\/j.1365-3024.2012.01379.x","article-title":"Decrease in anti-Leishmania IgG3 and IgG1 after cutaneous leishmaniasis lesion healing is correlated with the time of clinical cure","volume":"34","author":"Fagundes-Silva","year":"2012","journal-title":"Parasite Immunol"},{"issue":"11","key":"10.1016\/j.ijid.2021.02.016_bib0075","doi-asserted-by":"crossref","first-page":"E54","DOI":"10.1086\/340261","article-title":"Epidemiologic and immunologic findings for the subclinical form of Leishmania braziliensis infection","volume":"34","author":"Follador","year":"2002","journal-title":"Clin Infect Dis"},{"issue":"4","key":"10.1016\/j.ijid.2021.02.016_bib0080","first-page":"100046","article-title":"Humoral immunity in leishmaniasis \u2014 prevention or promotion of parasite growth?","volume":"2","author":"Goncalves","year":"2020","journal-title":"Cytokine"},{"issue":"1","key":"10.1016\/j.ijid.2021.02.016_bib0085","doi-asserted-by":"crossref","first-page":"37","DOI":"10.1016\/S0733-8635(18)30200-6","article-title":"Laboratory tests for the diagnosis and evaluation of leishmaniasis","volume":"12","author":"Kalter","year":"1994","journal-title":"Dermatol Clin"},{"issue":"3","key":"10.1016\/j.ijid.2021.02.016_bib0090","doi-asserted-by":"crossref","first-page":"809","DOI":"10.4049\/jimmunol.118.3.809","article-title":"Immune response to immunization via the anterior chamber of the eye. I. F. lymphocyte-induced immune deviation","volume":"118","author":"Kaplan","year":"1977","journal-title":"J Immunol"},{"issue":"6","key":"10.1016\/j.ijid.2021.02.016_bib0095","doi-asserted-by":"crossref","first-page":"376","DOI":"10.1016\/j.trstmh.2012.03.007","article-title":"A proposed new clinical staging system for patients with mucosal leishmaniasis","volume":"106","author":"Lessa","year":"2012","journal-title":"Trans R Soc Trop Med Hyg"},{"issue":"1","key":"10.1016\/j.ijid.2021.02.016_bib0100","doi-asserted-by":"crossref","first-page":"22","DOI":"10.1186\/s12879-018-3653-0","article-title":"Performance of serological tests PGL1 and NDO-LID in the diagnosis of leprosy in a reference Center in Brazil","volume":"19","author":"Leturiondo","year":"2019","journal-title":"BMC Infect Dis"},{"issue":"2","key":"10.1016\/j.ijid.2021.02.016_bib0105","doi-asserted-by":"crossref","first-page":"223","DOI":"10.1086\/524042","article-title":"Clinical and parasite species risk factors for pentavalent antimonial treatment failure in cutaneous leishmaniasis in Peru","volume":"46","author":"Llanos-Cuentas","year":"2008","journal-title":"Clin Infect Dis"},{"issue":"6","key":"10.1016\/j.ijid.2021.02.016_bib0110","doi-asserted-by":"crossref","first-page":"1687","DOI":"10.1086\/515297","article-title":"Immunologic determinants of disease evolution in localized cutaneous leishmaniasis due to Leishmania major","volume":"177","author":"Louzir","year":"1998","journal-title":"J Infect Dis"},{"issue":"8","key":"10.1016\/j.ijid.2021.02.016_bib0115","doi-asserted-by":"crossref","first-page":"438","DOI":"10.1016\/j.trstmh.2011.05.002","article-title":"Reappraisal of the immunopathogenesis of disseminated leishmaniasis: in situ and systemic immune response","volume":"105","author":"Machado","year":"2011","journal-title":"Trans R Soc Trop Med Hyg"},{"issue":"6","key":"10.1016\/j.ijid.2021.02.016_bib0120","doi-asserted-by":"crossref","first-page":"788","DOI":"10.1086\/511643","article-title":"Oral pentoxifylline combined with pentavalent antimony: a randomized trial for mucosal leishmaniasis","volume":"44","author":"Machado","year":"2007","journal-title":"Clin Infect Dis"},{"issue":"6","key":"10.1016\/j.ijid.2021.02.016_bib0125","doi-asserted-by":"crossref","first-page":"945","DOI":"10.1093\/cid\/civ416","article-title":"Treatment of disseminated leishmaniasis with liposomal amphotericin B","volume":"61","author":"Machado","year":"2015","journal-title":"Clin Infect Dis"},{"issue":"3","key":"10.1016\/j.ijid.2021.02.016_bib0130","doi-asserted-by":"crossref","first-page":"837","DOI":"10.1128\/iai.62.3.837-842.1994","article-title":"Increased expression of proinflammatory cytokines in chronic lesions of human cutaneous leishmaniasis","volume":"62","author":"Melby","year":"1994","journal-title":"Infect Immun"},{"issue":"1","key":"10.1016\/j.ijid.2021.02.016_bib0135","doi-asserted-by":"crossref","first-page":"18","DOI":"10.1590\/S0074-02762013000100003","article-title":"Inflammation in disseminated lesions: an analysis of CD4+, CD20+, CD68+, CD31+ and vW+ cells in non-ulcerated lesions of disseminated leishmaniasis","volume":"108","author":"Mendes","year":"2013","journal-title":"Mem Inst Oswaldo Cruz"},{"issue":"5","key":"10.1016\/j.ijid.2021.02.016_bib0140","doi-asserted-by":"crossref","first-page":"747","DOI":"10.1084\/jem.20041470","article-title":"A role for IgG immune complexes during infection with the intracellular pathogen Leishmania","volume":"201","author":"Miles","year":"2005","journal-title":"J Exp Med"},{"issue":"4","key":"10.1016\/j.ijid.2021.02.016_bib0145","doi-asserted-by":"crossref","first-page":"570","DOI":"10.1093\/infdis\/jiw196","article-title":"Immunologic markers of protection in Leishmania (Viannia) braziliensis infection: a 5-year cohort study","volume":"214","author":"Muniz","year":"2016","journal-title":"J Infect Dis"},{"issue":"3","key":"10.1016\/j.ijid.2021.02.016_bib0150","doi-asserted-by":"crossref","first-page":"275","DOI":"10.1016\/S0035-9203(99)90021-4","article-title":"Evaluation of the direct agglutination test (DAT) using freeze-dried antigen for the detection of anti-Leishmania antibodies in stored sera from various patient groups in Ethiopia","volume":"93","author":"Oskam","year":"1999","journal-title":"Trans R Soc Trop Med Hyg"},{"issue":"1","key":"10.1016\/j.ijid.2021.02.016_bib0155","doi-asserted-by":"crossref","first-page":"67","DOI":"10.1093\/cid\/ciw662","article-title":"Fluconazole in the treatment of cutaneous leishmaniasis caused by Leishmania braziliensis: a randomized controlled trial","volume":"64","author":"Prates","year":"2017","journal-title":"Clin Infect Dis"},{"issue":"1","key":"10.1016\/j.ijid.2021.02.016_bib0160","doi-asserted-by":"crossref","first-page":"79","DOI":"10.4269\/ajtmh.1986.35.79","article-title":"Selection of a skin test antigen for American visceral leishmaniasis","volume":"35","author":"Reed","year":"1986","journal-title":"Am J Trop Med Hyg"},{"issue":"2","key":"10.1016\/j.ijid.2021.02.016_bib0165","doi-asserted-by":"crossref","first-page":"183","DOI":"10.4269\/ajtmh.1980.29.183","article-title":"Detection of circulating antibodies in cutaneous leishmaniasis by enzyme-linked immunosorbent assay (ELISA)","volume":"29","author":"Roffi","year":"1980","journal-title":"Am J Trop Med Hyg"},{"issue":"9","key":"10.1016\/j.ijid.2021.02.016_bib0170","doi-asserted-by":"crossref","first-page":"1304","DOI":"10.1086\/319990","article-title":"Comparison of cutaneous leishmaniasis due to Leishmania (Viannia) braziliensis and L. (V.) guyanensis in Brazil: clinical findings and diagnostic approach","volume":"32","author":"Romero","year":"2001","journal-title":"Clin Infect Dis"},{"issue":"3","key":"10.1016\/j.ijid.2021.02.016_bib0175","doi-asserted-by":"crossref","first-page":"645","DOI":"10.4269\/ajtmh.16-0539","article-title":"Characterization of the histopathologic features in patients in the early and late phases of cutaneous leishmaniasis","volume":"96","author":"Saldanha","year":"2017","journal-title":"Am J Trop Med Hyg"},{"issue":"1","key":"10.1016\/j.ijid.2021.02.016_bib0180","doi-asserted-by":"crossref","first-page":"75","DOI":"10.1111\/j.1365-2249.1993.tb05980.x","article-title":"Experimental murine paracoccidioidomycosis: relationship among the dissemination of the infection, humoral and cellular immune responses","volume":"94","author":"Singer-Vermes","year":"1993","journal-title":"Clin Exp Immunol"},{"issue":"1","key":"10.1016\/j.ijid.2021.02.016_bib0185","first-page":"101","article-title":"Immunoglobulin E antileishmanial antibody response in cutaneous leishmaniasis","volume":"9","author":"Sousa-Atta","year":"2002","journal-title":"Clin Diagn Lab Immunol"},{"issue":"4","key":"10.1016\/j.ijid.2021.02.016_bib0190","doi-asserted-by":"crossref","first-page":"777","DOI":"10.4269\/ajtmh.19-0531","article-title":"Clinical presentation and response to therapy in children with cutaneous leishmaniasis","volume":"102","author":"Suprien","year":"2020","journal-title":"Am J Trop Med Hyg"},{"issue":"3\u20134","key":"10.1016\/j.ijid.2021.02.016_bib0195","doi-asserted-by":"crossref","first-page":"248","DOI":"10.1016\/j.vetpar.2010.01.023","article-title":"Relationship of Leishmania-specific IgG levels and IgG avidity with parasite density and clinical signs in canine leishmaniasis","volume":"169","author":"Teixeira Neto","year":"2010","journal-title":"Vet Parasitol"},{"issue":"12","key":"10.1016\/j.ijid.2021.02.016_bib0200","doi-asserted-by":"crossref","first-page":"1829","DOI":"10.1086\/345772","article-title":"Disseminated leishmaniasis: a new and emerging form of leishmaniasis observed in northeastern Brazil","volume":"186","author":"Turetz","year":"2002","journal-title":"J Infect Dis"},{"issue":"11","key":"10.1016\/j.ijid.2021.02.016_bib0205","doi-asserted-by":"crossref","first-page":"3892","DOI":"10.1128\/JCM.r00764-11","article-title":"Serial quantitative PCR assay for detection, species discrimination, and quantification of Leishmania spp. in human samples","volume":"49","author":"Weirather","year":"2011","journal-title":"J Clin Microbiol"}],"container-title":["International Journal of Infectious Diseases"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1201971221001028?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1201971221001028?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,22]],"date-time":"2025-10-22T07:57:13Z","timestamp":1761119833000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1201971221001028"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,5]]},"references-count":41,"alternative-id":["S1201971221001028"],"URL":"https:\/\/doi.org\/10.1016\/j.ijid.2021.02.016","relation":{},"ISSN":["1201-9712"],"issn-type":[{"value":"1201-9712","type":"print"}],"subject":[],"published":{"date-parts":[[2021,5]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Anti-Leishmania IgG is a marker of disseminated leishmaniasis caused by Leishmania braziliensis","name":"articletitle","label":"Article Title"},{"value":"International Journal of Infectious Diseases","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.ijid.2021.02.016","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2021 The Authors. Published by Elsevier Ltd on behalf of International Society for Infectious Diseases.","name":"copyright","label":"Copyright"}]}}